Abstract
NAD(P)HX dehydratase (NAXD) catalyzes the recovery of toxic derivatives of nicotinamide
adenine dinucleotides which play an essential role in mitochondrial metabolism. Mutations
in NAXD were recently shown to cause early-onset neurodegeneration exacerbated by febrile
illness. Here, we report a novel homozygous stop-gain variant in NAXD in an infant who presented with a fulminant course of autoinflammation, dermatitis,
colitis, and cystic encephalomalacia beginning at 3 weeks of age. Our findings support
the central role of NAXD-mediated metabolite repair for normal tissue function and
implicate innate immune processes in the pathogenesis of NAXD deficiency.
Keywords
NAXD - mitochondria - cystic encephalomalacia